Navigation Links
The first impact factor for PLoS Biology ?13.9

The open-access journal PLoS Biology has been assessed by Thomson ISI to have an impact factor of 13.9*, which places PLoS Biology among the most highly cited journals in the life sciences. This is an outstanding statistic for a journal less than two years old, from a new publisher promoting a new business model that supports open access to the scientific and medical literature.

An impact factor of 13.9 places PLoS Biology above such established journals as EMBO Journal, Current Biology, and the Proceedings of the National Academy of Sciences. In fact, in ISI's category of general biology journals, PLoS Biology is ranked number 1.

PLoS Biology was launched in October 2003, as an open-access home to the very best in biological research. By any measure, the impact of this launch was impressive. The on-line publication of the first issue was accompanied by strong and favorable media coverage, and subsequent issues continue to receive regular attention. Content from PLoS Biology has been read, copied, redistributed, and reused, without restriction (aside from proper citation of the authors), and now we know that the journal has also been cited time and time again.

PLoS Biology was launched to provide biologists who support open access a high profile journal for their best research papers and to demonstrate that open-access publishing works for a selective journal that only publishes outstanding science. Thanks to support from funding agencies, librarians, open-access advocates, and the scientific community ?in particular, the editorial board members of PLoS Biology, the reviewers, and most of all the authors who have submitted excellent work to a fledgling journal ?a substantial step has been taken toward these goals.

But there is still a long way to go before the mission of the Public Library of Science ?to make the world's treasury of scientific and medical literature a public resource ?is fulfilled. We hope that PLoS Biology's first imp act factor will inspire even greater support for PLoS journals and for open access.

* Thomson ISI calculated the impact factors that it announced this year by counting all the citations in 2004 to content that appeared in 2002 and 2003 and then dividing that number by the number of articles published in 2002 and 2003. For a long-standing journal, therefore, this number reflects the mean (average) number of citations over the course of a year to articles published over the two prior years. For PLoS Biology, this number refers only to articles published in its first three issues in the fall of 2003, which is why the initial impact factor is considered preliminary.


'"/>

Source:Public Library of Science


Related biology news :

1. A genes first kiss sets off that affair known as puberty
2. Love at first smell
3. Worlds largest rainforest drying experiment completes first phase
4. PCRM develops worlds first cruelty-free insulin assay
5. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses
6. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
7. DuPonts first biologically derived polymer receives global recognition
8. Anti cancer virotherapy well tolerated in first human administration, research finds
9. Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development
10. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
11. Researchers find first evidence of venom system in extinct mammal
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... MedNet,s significant achievements are the result of the company,s ... iMedNet eClinical , it,s comprehensive, easy-to-use and ... --> Key MedNet growth achievements in ...
(Date:1/13/2016)... York , January 13, 2016 ... Research has published a new market report titled - Biometric ... Trends, and Forecast, 2015 - 2023. According to the report, ... 2014 and is anticipated to reach US$1,625.8 mn by ... to 2023. In terms of volume, the biometric sensors ...
(Date:1/8/2016)... ANGELES and MANCHESTER, United Kingdom ... ("BBI"), a developer of innovative sensor-based diagnostic products, today announced ... financed by new and existing investors.  Proceeds from the financing ... SEM Scanner , a hand-held device for detecting early-stage pressure ... Ireland after receiving CE Mark approval. ...
Breaking Biology News(10 mins):
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
(Date:2/3/2016)... 2016  With the growing need for better ... underway, therapies such as monoclonal antibodies, recombinant protein ... of indications are in high demand. Conventionally expression ... and production of these therapeutics. However, due to ... costs, novel approaches and novel expression systems are ...
(Date:2/3/2016)... Feb. 3, 2016 Harvard Apparatus Regenerative ... company developing bioengineered organ implants for life-threatening conditions ... that CEO Jim McGorry , will present ... on Tuesday, February 9, 2016 at 8:00 ... . HART,s presentation will be webcast live ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology: